As per a recent study released by Maximize Market Research, titled, “Genetic Engineering Market”. The global genetic engineering market was valued at USD 1.27 billion in 2023 and is projected to climb to USD 5.64 billion by 2030, representing a compound annual growth rate (CAGR) of 23.7%.
Genetic Engineering Market Overview:
The genetic engineering market is undergoing a significant transformation as advances in biotechnology, gene editing, and synthetic biology converge to enable more precise, efficient modification of organisms. From laboratory-based modifications of DNA to the introduction of entirely new traits into plants, animals and microbes, the field is expanding its footprint across agriculture, medicine and industrial biotech.
Originally rooted in recombinant DNA technology and traditional genetic modification, the sector now encompasses cutting-edge techniques such as CRISPR/Cas9 gene editing, gene silencing, and synthetic gene insertion. These methods are increasingly used not only to create genetically modified organisms (GMOs) in agriculture but also to develop biopharmaceuticals, gene therapies and environmentally oriented biotech interventions.
Download a Free Sample Report Today : https://www.maximizemarketresearch.com/request-sample/208710/
Genetic Engineering Market Dynamics
A major driver of market growth is the rising demand for genetically modified organisms (GMOs) in agriculture, where engineered plants and livestock are sought for traits such as pest resistance, herbicide tolerance, improved nutritional profiles, and longer shelf life. Adoption by farmers is accelerating in key regions, boosting downstream demand for engineering technologies. At the same time, the market faces non-technical challenges: complex regulatory frameworks, ethical concerns (germline editing, “designer” traits), intellectual property issues and ecological risk concerns are restraining faster uptake in some geographies.
Simultaneously, the healthcare and pharmaceutical sectors are increasingly leveraging genetic engineering — from production of biopharmaceuticals like insulin and vaccines, to more advanced gene therapies targeting rare diseases and conditions previously seen as untreatable. Advances in gene editing and synthetic biology are shortening drug-development timelines and offering new therapeutic avenues.
Genetic Engineering Market Outlook and Future Trends :
Over the next several years, growth is expected to remain very strong as companies and research institutions push into next-generation gene editing, synthetic biology and precision breeding. Enhanced throughput of gene synthesis, more refined editing tools (beyond first-gen CRISPR), and scale-up in manufacturing of engineered organisms/biologics will underpin further expansion.
Another key trend will be the integration of data-driven biotech — AI and machine learning applied to genomic data, automated “lab-in-a-box” gene engineering pipelines, and modular engineered organisms for industrial/bioremediation uses. As these mature, genetic engineering becomes less the domain of elite labs and more widely accessible, shifting the cost and scale curve.
Genetic Engineering Market Regional Insights:
The market’s regional profile shows clear leaders and fast-growth zones. In 2023, North America dominated the global genetic engineering market share, driven by heavy investment in gene technologies, well-developed biotech and pharma industries, and friendly regulatory/innovation ecosystems. The U.S., in particular, leads in R&D, both in academic and commercial settings. Europe ranks second, bolstered by strong biotech clusters, advanced healthcare infrastructure and gene therapy / genomic research investments. However, regulatory complexity and public scrutiny of GMOs and edited organisms pose higher friction in parts of the region. The Asia-Pacific region is emerging as a high-potential market: countries like China, India, Japan, South Korea and Australia are ramping up biotech R&D, agricultural engineering programmes and gene therapy development initiatives.
Genetic Engineering Market Segmentation
by Product
Biochemical
Genetic Markers
by Techniques
Gene Splicing
Artificial Selection
Recombinant DNA Technology
Synthesizing DNA
Gene Editing
Other
by Application
Agriculture
Medical Industrial
Healthcare and Pharmaceuticals
Other
by End-User
Biotechnology Companies
Pharmaceutical Manufacturers
Academic and Research Institutions
Other
Some of the current players in the Genetic Engineering Market are:
1. Thermo Fisher Scientific Inc.
2. Herbert Boyer
3. Merck KGaA (EMD Millipore)
4. Lonza Group Ltd.
5. Horizon Discovery Group plc
6. GenScript Biotech Corporation
7. CRISPR Therapeutics AG
8. Editas Medicine, Inc.
9. Sangamo Therapeutics, Inc.
10. Intellia Therapeutics, Inc.
11. Cellectis S.A.
12. Precision BioSciences Inc.
13. New England Biolabs, Inc.
14. Takara Bio Inc.
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 [email protected]
